Roche’s faricimab shows strong durability in diabetic macular edema trials
Roche has announced positive topline results from two identically designed global phase III studies of...
Novartis’ oral therapy shows superior MMR rate in leukaemia trial
Novartis has reported positive results from the Phase III ASCEMBL study of the oral investigational...
Roche reports long-term data from leukaemia drug trials
Roche has announced that data from the pivotal Phase III MURANO and CLL14 studies support...
Does Arcturus’ one-shot Covid-19 vaccine have the potential to match up with leading BioNTech/Pfizer and Moderna candidates?
Leading COVID-19 vaccine candidates from Pfizer/BioNTech (BNT-162b2) and Moderna (mRNA-1273) currently in Phase III trials...
Novartis’ arthritis drug fails to meet endpoints in Covid-19 trial
Novartis has announced that its arthritis drug, canakinumab, failed to meet its primary endpoint in...
Novartis reports reduction of synovitis in psoriatic arthritis trial
Novartis has announced that 12-week results from the Phase IIIb ULTIMATE trial of Cosentyx (secukinumab)...
NeuroRx and Relief Therapeutics to continue Covid-19 trial of RLF-100
NeuroRx and Relief Therapeutics have announced that the independent Data Monitoring Committee (DMC) has voted...
ADC Therapeutics initiates dosing in solid tumour trial
ADC Therapeutics has dosed the first patient with camidanlumab tesirine (Cami, formerly ADCT-301) in combination...
Novartis’ migraine medicine trial meets endpoints
Novartis has announced that first Phase IV HER-MES study of Aimovig (erenumab) against topiramate in...
Novartis reports positive results from Cosentyx trial
Novartis has reported that data from two pivotal Phase III trials of Cosentyx (secukinumab) demonstrated...